Indian drugmakers are developing their versions of Novo Nordisk's weight-loss treatment, Wegovy, aiming to capitalize on the growing weight...

Approved by the Indian drug regulator in May 2023, sovateltide can be administered within 24 hours for the treatment of ischemic stroke, al...

With this funding, Mumbai-based Neodocs aims to double down its investments in existing products, particularly focusing on its kidney care ...

Sun Pharma has partnered up with Bayer to market Finerenone, a drug for chronic kidney disease, in India. Bayer grants non-exclusive rights...

Sharvil Patel, managing director of Zydus Lifesciences said, half of the research and development (R&D) allocation is geared towards develo...

“The addition of RYTSTAT further strengthens our nephrology portfolio in India," said Kirti Ganorkar, CEO - India Business, Sun Pharma.

Anglo-Swedish pharma company AstraZeneca has mobilised research efforts to advance the development of a novel coronavirus-neutralising long...

A voluntary licence (VL) is an authorisation given by the patent holder to a generic company to produce a patented drug while a compulsory ...

On May 22, there were 8,848 cases across India according to the central government. By May 26, the total number of cases went up to 11,717,...

As per the terms of the agreement, Sun Pharma will be the exclusive development and commercialisation partner for Triferic during the term ...

"India has a strong potential to become a hub for bio-pharma innovation and play a leading role in collaborative research for the same."

This will have a huge economic impact creating high paying jobs, intellectual property and the real possibility for India to play a leading...

The country has resorted to its liberal use while objecting to concession on cancer drug by India.

Temporary importation of unapproved foreign drugs is considered in rare cases when there is a shortage of an approved drug that is critical...

Leading domestic drugmakers have decided to collectively challenge frivolous patent applications filed by multinationals in India under the...

Markets are expected to be under pressure on Monday tracking sluggish cues from global markets.

Sun Pharmaceutical Industries has received approval from USFDA for abbreviated new drug application of amifostine for injection 500mg.